Company news

На странице:
Indonesia registers Russian drug with proven clinical efficacy against coronavirus Avifavir was the first ...
24.03.2021
Chromis (Russia), a joint venture of the ChemRar Group and the Russian Direct Investment Fund (RDIF), and its partner ...
10.03.2021
The results of the two phases of the clinical trial of Avifavir for coronavirus treatment were presented at the ...
20.11.2020
Under the Government order on financing the purchase of drugs for the treatment of outpatients with the COVID-19 ...
09.11.2020
 Efficacy of favipiravir-based drugs against COVID-19 has been confirmed by clinical trials in Russia and Japan ...
24.09.2020
Moscow, September 23, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar ...
23.09.2020
Moscow, September 21, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar ...
21.09.2020
Moscow, August 3, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
03.08.2020
Moscow, August 3, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
03.08.2020
Research and Development institute “ChemRar” has created a unique platform for innovation drug discovery against novel ...
20.07.2020
Moscow, July 14, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
14.07.2020
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group, supported by the Russian ...
13.07.2020